StockTipsArenaBeta

BUY Windlas Biotech Limited — Akshay Bhagwat, JM Financial

BUYWindlas Biotech Limited

byAkshay Bhagwat, JM FinancialHorizon: 1–3 months2 Sept 2026via Business Today

Entry₹1,064Inferred
Target₹1,200
Total upside +12.78%
Stop lossNot given
CMP₹1,154.75Just now
Active+8.53%+3.92%upside left 3 mo left
Follow Akshay Bhagwat for new calls(50% target hit, 34 closed calls)Get alertsWatch WINDLAS for new buy/sell callsGet alertsSee 8 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Sept, 3:48 pm IST
5 supporting1 neutral1 opposing
Supports the BUY call (5)

MACD above its signal line — bullish momentum

Technicals · macd·7 Sept · today

Past month's volume 7.7× the prior month's average

Technicals · volume·4 Sept · 3d ago

Volume shocker stocks: Why share price of EMS, Expleo Solutions, Windlas Biotech, AKI India, Heritage Foods are up today

NewsLivemint·2 Sept · 5d ago

(opens in new tab)

1 advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·31 Aug · 1w ago

Windlas Biotech Limited reported Q1 FY27 financial results with revenue of Rs 248 crores, an 18% YoY growth. Adjusted EBITDA grew 26% YoY to Rs 34 crores, and Adjusted PAT grew 37% YoY to Rs 25 crores

NSE · Press Release·10 Aug · 4w ago

(opens in new tab)
Neutral / worth noting (1)

Windlas Biotech Limited has announced its financial results for the first quarter of the fiscal year 2027.

BSE · Company Update·10 Aug · 4w ago

(opens in new tab)
Weighs against the BUY call (1)

RSI at 86 — overbought territory

Technicals · rsi·7 Sept · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.